| Rosanny Espinal-witter, MD | |
|
5149 N 9th Ave, Pensacola, FL 32504-8779 | |
| (850) 416-6303 | |
| Not Available |
| Full Name | Rosanny Espinal-witter |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 18 Years |
| Location | 5149 N 9th Ave, Pensacola, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578720025 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Hospital | Pensacola, FL | Hospital |
| Gulf Breeze Hospital | Gulf breeze, FL | Hospital |
| Sacred Heart Hospital | Pensacola, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vivid Pathology Pa | 9133106784 | 10 |
| Vivid Pathology Pa | 9133106784 | 10 |
News Archive
Metabolic Solutions Development Company, a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced today that it has launched a Phase 2a trial for MSDC-0602, the company's second drug candidate for the treatment of type 2 diabetes.
Duke Medicine researchers have identified a receptor in the nervous system that may be key to preventing epilepsy following a prolonged period of seizures.
A team led by a scientist from The Scripps Research Institute has been awarded a five-year, $10.2 million grant from the National Eye Institute (NEI) to develop a new type of treatment for diabetic retinopathy, macular degeneration, and other common vision disorders.
A recent study by investigators at the National Institute of Diabetes, Digestive and Kidney Diseases at the National Institutes of Health measured how much artificial sweetener is absorbed into the blood stream by children and adults after drinking a can of diet soda.
Canadian researchers have developed a vaccine to stop the progression of multiple sclerosis (MS) and they say encouraging results have already been seen.
› Verified 3 days ago
| Entity Name | West Florida Medical Center Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568452688 PECOS PAC ID: 7416860705 Enrollment ID: O20031113000322 |
News Archive
Metabolic Solutions Development Company, a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced today that it has launched a Phase 2a trial for MSDC-0602, the company's second drug candidate for the treatment of type 2 diabetes.
Duke Medicine researchers have identified a receptor in the nervous system that may be key to preventing epilepsy following a prolonged period of seizures.
A team led by a scientist from The Scripps Research Institute has been awarded a five-year, $10.2 million grant from the National Eye Institute (NEI) to develop a new type of treatment for diabetic retinopathy, macular degeneration, and other common vision disorders.
A recent study by investigators at the National Institute of Diabetes, Digestive and Kidney Diseases at the National Institutes of Health measured how much artificial sweetener is absorbed into the blood stream by children and adults after drinking a can of diet soda.
Canadian researchers have developed a vaccine to stop the progression of multiple sclerosis (MS) and they say encouraging results have already been seen.
› Verified 3 days ago
| Entity Name | Vivid Pathology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760738611 PECOS PAC ID: 9133106784 Enrollment ID: O20040709000754 |
News Archive
Metabolic Solutions Development Company, a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced today that it has launched a Phase 2a trial for MSDC-0602, the company's second drug candidate for the treatment of type 2 diabetes.
Duke Medicine researchers have identified a receptor in the nervous system that may be key to preventing epilepsy following a prolonged period of seizures.
A team led by a scientist from The Scripps Research Institute has been awarded a five-year, $10.2 million grant from the National Eye Institute (NEI) to develop a new type of treatment for diabetic retinopathy, macular degeneration, and other common vision disorders.
A recent study by investigators at the National Institute of Diabetes, Digestive and Kidney Diseases at the National Institutes of Health measured how much artificial sweetener is absorbed into the blood stream by children and adults after drinking a can of diet soda.
Canadian researchers have developed a vaccine to stop the progression of multiple sclerosis (MS) and they say encouraging results have already been seen.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rosanny Espinal-witter, MD 5700 Southwyck Blvd, Toledo, OH 43614-1509 Ph: (800) 288-8325 | Rosanny Espinal-witter, MD 5149 N 9th Ave, Pensacola, FL 32504-8779 Ph: (850) 416-6303 |
News Archive
Metabolic Solutions Development Company, a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced today that it has launched a Phase 2a trial for MSDC-0602, the company's second drug candidate for the treatment of type 2 diabetes.
Duke Medicine researchers have identified a receptor in the nervous system that may be key to preventing epilepsy following a prolonged period of seizures.
A team led by a scientist from The Scripps Research Institute has been awarded a five-year, $10.2 million grant from the National Eye Institute (NEI) to develop a new type of treatment for diabetic retinopathy, macular degeneration, and other common vision disorders.
A recent study by investigators at the National Institute of Diabetes, Digestive and Kidney Diseases at the National Institutes of Health measured how much artificial sweetener is absorbed into the blood stream by children and adults after drinking a can of diet soda.
Canadian researchers have developed a vaccine to stop the progression of multiple sclerosis (MS) and they say encouraging results have already been seen.
› Verified 3 days ago
Mats O Sanden, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 8383 N Davis Hwy, Pensacola, FL 32514 Phone: 850-494-5550 Fax: 850-494-3328 | |
Dr. James Cooper Valentine Jr., M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 220 Hovey Rd, Pensacola, FL 32508 Phone: 850-452-9484 | |
Dr. Chi Kim Nguyen, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5149 N Ninth Avenue, Pensacola, FL 32504 Phone: 850-416-6894 Fax: 850-416-2487 | |
Dr. Charles Allen Mayfield, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5149 N 9th Ave, Pensacola, FL 32504 Phone: 850-416-6303 Fax: 850-416-2487 | |
North Joseph Davis, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 4724 North Davis Hwy, 2nd Floor, Pensacola, FL 32503 Phone: 850-438-1154 Fax: 850-433-6034 | |
Dr. Thomas I King, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 8333 N Davis Hwy, Pensacola, FL 32514 Phone: 850-474-8581 Fax: 850-474-8021 | |
Dr. Charles Emerson Farmer, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5149 N 9th Ave, Pensacola, FL 32504 Phone: 850-416-3303 Fax: 850-416-6475 |